A randomized controlled trial demonstrated a significantly reduced incidence of type 2 diabetes among individuals with metabolic syndrome who received daily metformin with or without a Mediterranean ...

Olatec Therapeutics, Inc., a leader in the developing class of selective NLRP3 inhibitors, today announced that long-time ...

Dr. Priya Shah, DO works in Mount Laurel, NJ as a Diabetes & Metabolism Endocrinologist. Dr. Shah is board certified in Endocrinology. At present, Dr. Shah has received an average rating of 4.7 ...

Prominently featured in The Inner Circle, Rimah A. Sharief, MD, FAAP, is acknowledged as a Pinnacle Lifetime Member for her contributions to Pediatric Endocrinology.

Santa Barbara, CA (January 27, 2025) — Sansum Diabetes Research Institute (SDRI) proudly announces that Dr. Francine Kaufman, ...

AdventHealth Medical Group is pleased to announce that Phoebe Carpenter, APRN-CNP, joins Medical Group Endocrinology at ...

SGLT2 inhibitors confer greater risk reductions for major adverse cardiovascular events in older adults with type 2 diabetes compared with younger adults, according to findings from a systematic ...

This post was updated Jan. 31 at 12:28 a.m. Dr. Stephanie Smooke Praw, the interim clinical chief of UCLA Health’s Division ...

January is Thyroid Awareness Month, highlighting the importance of thyroid health and early detection of disorders. Sol Endocrinology provides expert care with screenings, resources, and personalized ...

Hospital for Special Surgery (HSS), the world's leading academic medical center specialized in musculoskeletal health, today announced the appointment of Matthew T. Drake, MD, PhD, chief of the ...

Drake, MD, PhD, chief of the Division of Endocrinology and director of the Metabolic Bone Service. Effective January 1, 2025. Dr. Drake will assume these duties from Emily Stein, MD, MS ...